Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 1
2008 2
2009 1
2010 1
2011 2
2012 1
2013 1
2014 3
2015 3
2016 5
2017 1
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Effect of duodenal glucose load on blood pressure in type 2 diabetes.
Marathe CS, Horowitz M, Trahair LG, Bound M, Checklin H, Lange K, Rayner CK, Jones KL. Marathe CS, et al. Among authors: checklin h. Diabetes Res Clin Pract. 2016 Mar;113:38-40. doi: 10.1016/j.diabres.2016.01.024. Epub 2016 Jan 22. Diabetes Res Clin Pract. 2016. PMID: 26972959
A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial.
Watson LE, Phillips LK, Wu T, Bound MJ, Checklin HL, Grivell J, Jones KL, Clifton PM, Horowitz M, Rayner CK. Watson LE, et al. Among authors: checklin hl. Diabetes Obes Metab. 2019 Apr;21(4):930-938. doi: 10.1111/dom.13604. Epub 2019 Jan 4. Diabetes Obes Metab. 2019. PMID: 30520216 Clinical Trial.
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, Checklin HL, Bound MJ, Rigda RS, Crouch B, Jones KL, Horowitz M, Rayner CK. Thazhath SS, et al. Among authors: checklin hl. Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15. Diabetes. 2016. PMID: 26470783 Clinical Trial.
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, Checklin HL, Bound MJ, Rigda RS, Horowitz M, Jones KL, Rayner CK. Thazhath SS, et al. Among authors: checklin hl. Diab Vasc Dis Res. 2017 Jan;14(1):59-63. doi: 10.1177/1479164116666761. Epub 2016 Oct 20. Diab Vasc Dis Res. 2017. PMID: 27941058 Free article. Clinical Trial.
Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
Thazhath SS, Wu T, Bound MJ, Checklin HL, Standfield S, Jones KL, Horowitz M, Rayner CK. Thazhath SS, et al. Among authors: checklin hl. Nutrition. 2016 May;32(5):553-9. doi: 10.1016/j.nut.2015.11.004. Epub 2015 Dec 7. Nutrition. 2016. PMID: 26792024 Clinical Trial.
Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin.
Wu T, Ma J, Bound MJ, Checklin H, Deacon CF, Jones KL, Horowitz M, Rayner CK. Wu T, et al. Among authors: checklin h. Diabetes. 2014 Aug;63(8):2776-87. doi: 10.2337/db13-1627. Epub 2014 Mar 19. Diabetes. 2014. PMID: 24647737 Clinical Trial.
19 results